SURG-30. DOES LEVETIRACETAM ACT AS A TEMOZOLOMIDE CHEMOSENSITIZER IN PATIENTS WITH GLIOBLASTOMA?

BACKGROUND: In a recent study, patients with glioblastoma (GBM) who administered Levetiracetam (LEV) during chemoradiotherapy were reported to have survival benefit. However, the effect of LEV on survival of glioblastoma patients is not well known. METHODS: From 2004 to 2016, 340 patients with surgi...

Disgrifiad llawn

Wedi'i Gadw mewn:
Manylion Llyfryddiaeth
Cyhoeddwyd yn:Neuro Oncol
Prif Awduron: Roh, Tae-Hoon, Kim, Se-Hyuk, Kang, Seok-Gu, Kim, Eui Hyun, Cho, Jaeho, Suh, Chang Ok, Kim, Se Hoon, Chang, Jong Hee
Fformat: Artigo
Iaith:Inglês
Cyhoeddwyd: Oxford University Press 2017
Pynciau:
Abstracts
Mynediad Ar-lein:https://ncbi.nlm.nih.gov/pmc/articles/PMC5692441/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/nox168.984
Tagiau: Ychwanegu Tag
Dim Tagiau, Byddwch y cyntaf i dagio'r cofnod hwn!

Eitemau Tebyg